CSCIF OTC
COSCIENS Biopharma Inc.
1W: +5.6%
1M: +29.3%
3M: -8.7%
YTD: +4.2%
$6.44
+0.02 (+0.31%)
Weekly Expected Move ±8.4%
$5
$6
$6
$7
$8
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$10M
-24.0% ▼
Gross Profit
$4M
-45.6% ▼
Operating Income
-$15M
+44.5% ▲
Net Income
-$14M
+5.5% ▲
EPS (Diluted)
$-4.57
+22.9% ▲
EBITDA
-$13M
+4.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $10M |
| YoY Growth | -24.0% |
| Cost of Revenue | $7M |
| Gross Profit | $4M |
| Gross Margin | 35.3% |
| R&D Expenses | $4M |
| SG&A Expenses | $14M |
| Operating Expenses | $18M |
| Operating Income | -$15M |
| Operating Margin | -139.3% |
| Interest Expense | $235K |
| Income Before Tax | -$14M |
| Tax Expense | $14K |
| Net Income | -$14M |
| Net Margin | -138.1% |
| EPS (Diluted) | $-4.57 |
| EBITDA | -$13M |
| Shares Outstanding | 3M |